Relationships between midembryonic 5-HT2 agonist and/or antagonist exposure and detour learning by chickens

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 1, 1998, Pages 47-53

  Bollweg, G ^a   Sparber, S B ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

5 HT2 receptor; Behavior; Cocaine; Developmental toxicity

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; COCAINE; OPIATE; RECEPTOR SUBTYPE; RITANSERIN; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CHICKEN; CONTROLLED STUDY; DEVELOPMENT; DOSE RESPONSE; DRUG WITHDRAWAL; EMBRYO; EMBRYO DEVELOPMENT; LEARNING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; VASOCONSTRICTION;

AMPHETAMINES; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CHICK EMBRYO; CHICKENS; FEMALE; HUMANS; LEARNING; MOTOR ACTIVITY; PREGNANCY; RECEPTORS, SEROTONIN; RITANSERIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TIME FACTORS;

ANIMALIA; GALLUS GALLUS;

EID: 0032077272     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00555-8     Document Type: Article

References (36)

1. 1A receptor-mediated neuroendocrine responses in male but not female rat progeny after prenatal cocaine. Evidence for gender differences J. Pharmacol. Exp. Ther. 271:1994;1453-1461.
2. Bollweg G., Sparber S. B. Ritanserin blocks DOI-altered embryonic motility and posthatch learning in the developing chicken. Pharmacol. Biochem. Behav. 55:1996;397-403.
3. Cabrera T. M., Levy A. D., Li Q., Van de Kar L. D., Battaglia G. Cocaine-induced deficits in ACTH and corticosterone responses in female rat progeny. Brain Res. Bull. 34:1994;93-97.
4. 2A/2C receptor density and function in male rat progeny following prenatal fluoxetine. J. Pharmacol. Exp. Ther. 269:1994;637-645.
5. Dow-Edwards D. L. Modification of acoustic startle reactivity by cocaine administration during the postnatal period. Comparison with a specific serotonin reuptake inhibitor Neurotoxicol. Teratol. 18:1996;289-296.
6. 2/1C antagonist, and negative symptoms in schizophrenia. A placebo controlled double blind trial. Br. J. Psychiatry. 163:1993;451-455.
7. Haydon P. G., McCobb D. P., Kater S. B. Serotonin selectively inhibits growth cone motility and synaptogenesis of specific identified neurons. Science. 226:1984;561-564.
8. Henderson M. G., McMillen B. A. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs. Teratology. 48:1993;421-430.
9. Holson R. R., Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol. Teratol. 14:1992;221-228.
10. Kleven M. S., Sparber S. B. Modification of quasi-morphine withdrawal with serotonin agonists and antagonists. Evidence for a role of serotonin in the expression of opiate withdrawal Psychopharmacology (Berlin). 98:1989;231-235.
11. Lauder J. M., Krebs H. Serotonin as a differentiation signal in early neurons. Dev. Neurosci. 1:1978;15-30.
12. Lauder J. M. Neurotransmitters as morphogens. Prog. Brain. Res. 73:1988;365-387.
13. Leysen J. E., Gommeren W., VanGompel P., Wynants J., Janssen P. F. M., Laduron P. M. Receptor binding properties in vitro and in vivo of ritanserin. A very potent and long acting serotonin-S2 antagonist Mol. Pharmacol. 27:1985;600-611.
14. Lorr N. A., Bloom S. E. Ontogeny of the chicken cytochrome P-450 enzyme system. Expression and development of responsiveness to phenobarbital induction. Biochem. Pharmacol. 36:1987;3059-3067.
15. McMahon D. Chemical messengers in development. A hypothesis Science. 185:1974;1012-1021.
16. Meert T., Awouters F., Niemegeers C. J. E., Schellekens K. H. L., Janssen P. A. J. Ritanserin reduces abuse of alcohol, cocaine and fentanyl in rats. Pharmacopsychiatry. 24:1991;159-163.
17. 2 antagonist, in heavy social drinkers. Desire to drink, alcohol intake and related effects Addiction. 90:1995;893-905.
18. Neal B. S., Sparber S. B. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine. J. Pharmacol. Exp. Ther. 236:1986;157-164.
19. Neal B. S., Sparber S. B. Long-term effects of neonatal exposure to isobutylmethylxanthine. I. Retardation of learning with antagonism by mianserin. Psychopharmacology (Berlin). 103:1991;388-397.
20. Neal B. S., Messing R. B., Sparber S. B. Long-term effects of neonatal exposure to isobutylmethylxanthine. II. Attenuation of acute morphine withdrawal in mature rats. Psychopharmacology (Berlin). 103:1991;398-406.
21. Nulman I., Rovet J., Stewart D. E., Wolpin J., Gardner H. A., Theis J. G. W., Kulin N., Koren G. Neurodevelopment of children exposed in utero to antidepressant drugs. N. Engl. J. Med. 336:1997;258-262.
22. Pangalila-Ratu Langi E. A., Jansen A. A. I. Ritanserin in the treatment of generalized anxiety disorders. A placebo controlled trial Hum. Psychopharmacol. 3:1988;207-212.
23. Reuhl K. Delayed expression of neurotoxicity. The problem of silent damage Neurotoxicology. 12:1991;341-346.
24. Rodier P. M. Developing brain as a target of toxicity. Environ. Health Perspect. 103(Suppl 6):1995;73-76.
25. Sanders-Bush E., Mayer S. E. 5-Hydroxytryptamine (serotonin) receptor agonists and antagonists. Hardman J. G. G., Gilman A., Limbird L. L. Goodman & Gilman's the pharmacological basis of therapeutics. 9:1996;McGraw-Hill, New York.
26. Sharpley A. L., Cowen P. J. Effect of pharmacologic treatments on the sleep of depressed patients. Biol. Psychiatry. 37:1995;85-98.
27. Sparber S. B. Effects of drugs on the biochemical and behavioral responses of developing organisms. Fed. Proc. 31:1972;74-80.
28. 2 antagonist ritanserin. Soc. Neurosci. Abstr. 229:1992;7.
29. Sparber S. B., Wasserman A., Bollweg G. Ritanserin (RIT) blocks the vasoconstriction caused by injection of cocaine (COC) into chicken eggs with 15 day-old embryos. NIDA Res. Monogr. 153:1994;169.
30. 2) receptors during late development of chicken embryos causes decreased embryonic motility, interferes with hatching and induces herniated umbilici. Pharmacol. Biochem. Behav. 53:1996;603-611.
31. Thiriet G., Kempf E., Ebel A. Cholinergic modulation through biogenic amines during development of the chick spinal cord. Dev. Brain Res. 78:1994;102-108.
32. Wallace J. A., Allgood P. C., Hoffman T. J., Mondragon R. M., Maez R. R. Analysis of the change in number of serotonergic neurons in the chick spinal cord during embryonic development. Brain Res. Bull. 17:1986;297-305.
33. Whitaker-Azmitia P. M., Azmitia E. Autoregulation of fetal serotonergic neuronal development. Role of high affinity serotonin receptors Neurosci. Lett. 67:1986;307-312.
34. Wilson J. G., Jordan H. C., Brent R. L. Effects of irradiation on embryonic development. Am. J. Anat. 92:1953;153-188.
35. Zamenhof S. Selective sensitive period in chick embryo. Toxic effect of exogenous neurotransmitters Cytobios. 58:1989;171-177.
36. Zhang, X.; Schrott, L.; Sparber, S. B.: Evidence for a serotonin-mediated effect of cocaine causing vasoconstriction and herniated umbilici in chicken embryos. Pharmacol. Biochem. Behav. (in press).